These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2630174)

  • 41. Smad interacting protein 1 as a regulator of skin fibrosis in pathological scars.
    Zhang ZF; Zhang YG; Hu DH; Shi JH; Liu JQ; Zhao ZT; Wang HT; Bai XZ; Cai WX; Zhu HY; Tang CW
    Burns; 2011 Jun; 37(4):665-72. PubMed ID: 21236582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Histopathological differential diagnosis of keloid and hypertrophic scar.
    Lee JY; Yang CC; Chao SC; Wong TW
    Am J Dermatopathol; 2004 Oct; 26(5):379-84. PubMed ID: 15365369
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nitric oxide produced by iNOS is associated with collagen synthesis in keloid scar formation.
    Hsu YC; Hsiao M; Wang LF; Chien YW; Lee WR
    Nitric Oxide; 2006 Jun; 14(4):327-34. PubMed ID: 16517189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders.
    Ogawa R; Akaishi S
    Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mast cells in pathological and surgical scars.
    Beer TW; Baldwin H; West L; Gallagher PJ; Wright DH
    Br J Ophthalmol; 1998 Jun; 82(6):691-4. PubMed ID: 9797674
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fibronectin. Localization in normal human skin, granulation tissue, hypertrophic scar, mature scar, progressive systemic sclerotic skin, and other fibrosing dermatoses.
    Nagata H; Ueki H; Moriguchi T
    Arch Dermatol; 1985 Aug; 121(8):995-9. PubMed ID: 3896159
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of the anti-allergic agent avil on abnormal scar fibroblasts.
    Venugopal J; Ramakrishnan M; Habibullah CM; Babu M
    Burns; 1999 May; 25(3):223-8. PubMed ID: 10323606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.
    Ogawa R
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287424
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vascularization pattern in hypertrophic scars and keloids: a stereological analysis.
    Amadeu T; Braune A; Mandarim-de-Lacerda C; Porto LC; Desmoulière A; Costa A
    Pathol Res Pract; 2003; 199(7):469-73. PubMed ID: 14521263
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Expression of mast cell tryptase in scar].
    Gao F; Zhao Y; Feng YQ; Huo R; Xue WJ; Wang FG; Lv RR; Xue F; Li Q; Zhang J
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2010 Mar; 26(2):132-5. PubMed ID: 20540319
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Co-localization of LTBP-2 with FGF-2 in fibrotic human keloid and hypertrophic scar.
    Sideek MA; Teia A; Kopecki Z; Cowin AJ; Gibson MA
    J Mol Histol; 2016 Feb; 47(1):35-45. PubMed ID: 26644005
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reconstructed human keloid models show heterogeneity within keloid scars.
    Limandjaja GC; van den Broek LJ; Waaijman T; Breetveld M; Monstrey S; Scheper RJ; Niessen FB; Gibbs S
    Arch Dermatol Res; 2018 Dec; 310(10):815-826. PubMed ID: 30370495
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Silver-stained nucleolar organizer regions in hypertrophic and keloid scars.
    Ghazizadeh M; Miyata N; Sasaki Y; Arai K; Aihara K
    Am J Dermatopathol; 1997 Oct; 19(5):468-72. PubMed ID: 9335240
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Experimental study of actin and myosin in the scar tissue].
    Zhang Q; Qian YL; Cui L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 Jan; 15(1):32-5. PubMed ID: 12563927
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studies on human scar tissue proteoglycans.
    Swann DA; Garg HG; Jung W; Hermann H
    J Invest Dermatol; 1985 Jun; 84(6):527-31. PubMed ID: 3998502
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypertrophic or keloid scars?
    McGrouther DA
    Eye (Lond); 1994; 8 ( Pt 2)():200-3. PubMed ID: 7958022
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Comparative study on biological characteristics and ultrastructure of the fibroblasts derived from normal skin, hypertrophic scar and keloidin in vitro culture].
    Song W; Sun G; Guan Z
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1998 Nov; 14(6):410-3. PubMed ID: 10452076
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dietary compounds inhibit proliferation and contraction of keloid and hypertrophic scar-derived fibroblasts in vitro: therapeutic implication for excessive scarring.
    Phan TT; Sun L; Bay BH; Chan SY; Lee ST
    J Trauma; 2003 Jun; 54(6):1212-24. PubMed ID: 12813346
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TGF-beta2 activates proliferative scar fibroblasts.
    Smith P; Mosiello G; Deluca L; Ko F; Maggi S; Robson MC
    J Surg Res; 1999 Apr; 82(2):319-23. PubMed ID: 10090846
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of TGF-beta2 on proliferative scar fibroblast cell kinetics.
    Polo M; Smith PD; Kim YJ; Wang X; Ko F; Robson MC
    Ann Plast Surg; 1999 Aug; 43(2):185-90. PubMed ID: 10454327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.